<DOC>
	<DOCNO>NCT00256347</DOCNO>
	<brief_summary>30 healthy volunteer enrol 6-session study . The first visit screening/orientation session . The next 5 visit ( full day ) outpatient session take place Monday Friday one week . All full day visit drug administration session subject randomized one two group . The primary purpose investigate time course development analgesic tolerance ( loss pain relieve effect ) morphine experimentally produce skin tenderness healthy volunteer .</brief_summary>
	<brief_title>Analgesic Tolerance Repeated Doses Subcutaneous Morphine</brief_title>
	<detailed_description>30 healthy volunteer enrol 6-session study . The first visit screening/orientation session . The next 5 visit ( full day ) outpatient session take place Monday Friday one week . All full day visit drug administration session subject randomized one two group . Group A receive two daily intramuscular injection 8 mg morphine Monday Thursday two intramuscular injection placebo Friday . Group B receive two daily intramuscular injection placebo Monday Thursday two intramuscular injection 8 mg morphine Friday . During Monday Friday session painfulness experimental heat application area skin tenderness ( primary secondary hyperalgesia ) assess two time intramuscular injection . Heat apply use computer control probe applies heat ( 450 C/1130 F ) thigh 3 minute ( Brief Thermal Sensitization model . )</detailed_description>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>1 . Healthy volunteer 2150 year age , 2 . If female , must nonlactating , pregnant , use reliable contraception method ( i.e . abstinence , intrauterine device [ IUD ] , hormonal birth control , double barrier method [ male condom , female condom , diaphragm plus spermicidal agent contraceptive foam , jelly cream ] ) . 3 . In stable health 4 . Must weigh 110 200 lb Body Mass Index 20 30 . 5 . Able willing provide write informed consent 6 . Able understand follow instruction investigator , include pain intensity rating scale 7 . Develops temporary secondary hyperalgesia brief thermal sensitization stimulation procedure perform screen visit ( Session 1 ) 8 . Opioid naïve ( previous history long term opioid use ) 1 . Severe coronary artery disease , uncontrolled hypertension , cardiac ventricular conduction abnormality , orthostatic mean blood pressure drop &gt; 25 mmHg , severe chronic obstructive pulmonary disease . 2 . History renal hepatic failure . 3 . Evidence hepatic , hematological , renal dysfunction base judgment physician . 4 . Subjects receive treatment topical steroid area stimulate . 5 . Dermatopathology , skin hypersensitivity , skin lesion area measurement thigh forearm . 6 . Allergy opioids . 7 . Concomitant treatment anticonvulsant , antidepressant , NMDA blocker , muscle relaxant , sedative , psychotropic drug opioids . 8 . Is currently take take monamine oxidase inhibitor ( MAOI ) drug within two week prior study medication session . 9 . Use NSAIDs acetaminophen within 36 hour drug treatment session and/or use caffeine alcohol begin 24 hour prior first drug treatment session . 10 . Use longacting NSAIDs piroxicam naproxen ( Naprosyn ) within 1 week oral drug treatment session . 11 . Heat pain detection thresholds 47°C/116.6°F arm ( see ) . 12 . Subjects within follow parameter weight : 110 200 pound 20 30 use Body Mass Index . 13 . Subjects unable read speak English . 14 . Diagnosis insulinrequiring diabetes mellitus . 15 . Current diagnosis drug alcohol abuse history opioid drug abuse 16 . Use opioids alcohol study , confirm urine drugscreen Session 1 Session 2 breathalyzer alcohol Sessions 26 . 17 . Neurological dysfunction psychiatric disorder severe enough interfere assessment pain sensory system . 18 . Has receive investigational drug within 30 day prior Study Visit 2 schedule receive another opioid medication course study . 19 . Chronic pain condition require regular physician visit prescription medication use daily basis . 20 . Subjects opinion investigator consider unable adhere schedule appointment , unlikely comply study protocol , unsuitable reason .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>